ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 1041-1048

  Charpin, Colette ^a,b   Bergeret, Denise ^b   Garcia, Stéphane ^a   Andrac, Lucile ^a,b   Martini, François ^a   Horschowski, Nicole ^b   Choux, Régine ^b   Lavaut, Marie Noëlle ^a  

^a HÔPITAL NORD   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Breast carcinoma; ELAM; Immunodetection

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HERMES ANTIGEN; SELECTIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 3;

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CELL ADHESION; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0031966467     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.5.1041     Document Type: Article

References (40)

1. Zetter BR: Adhesion molecules in tumor metastasis. Cancer Biol 4: 219-229, 1993.
2. Wellicome SM, Thomhill MH, Pitzalis C, et al: A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1 or lipopolysaccaride. J Immunol 144: 2558-2565, 1990.
3. Kyan-Aung U, Haskard DO, Poston RN, et al: Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 146: 521-528, 1991.
4. Thornhill MH, Wellicome SM, Mahiouz DL, et al: Tumor necrosis combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol 146: 592-598, 1991.
5. Fries JWU, Williams AJ, Atkins RC, et al: Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol 143: 725-737, 1993.
6. Giavazzi R, Garofalo A, Bani MR, et al: Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 50: 4771-4775, 1990.
7. Kaji M, Ishikura H, Kishimoto T, et al: E-Selectin expression induced by pancreas-carcinoma-derived interleukin-1α results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells. Int J Cancer 60: 712-717, 1995,
8. Ye C, Kiriayama K, Mistuoka C, et al: Expression of E-Selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 61: 455-460, 1995.
9. Fox SB, Turner GDH, Gatter KC and Harris AL: The increased expression of adhesion molecules ICAM-3, E- and P-Selectins on breast cancer endothelium. J Pathol 177: 369-376, 1995.
10. Zetter BR: The cellular basis of site-specific metastasis. N Engl J Med 322: 605-612, 1990.
11. Auerbach R, Lu, WC, Pardon E, et al: Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res 47: 1492-1496, 1987.
12. x determinant on myeloid and tumor cells. Science 250: 1132-1135, 1990.
13. Tiemeyer M, Swiedler SJ, Ishihara M, et al: Carbohydrate ligands for endothelial-leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88: 1138-1142, 1991.
14. x blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res 49: 745-752, 1989.
15. Dejana E, Martin-Padura I, Lauri D, et al: Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab Invest 66: 324-330, 1992.
16. Groves RW, Allen MH, Ross EL, et al: Expression of selectin ligands by cutaneous squamous cell carcinoma. Am J Pathol 143: 1220-1225, 1993.
17. Schadendorf D, Heidel J, Gawlik C, Suter L and Czarnetzki BM: Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 87: 366-371, 1995.
18. Matsuura N, Narita T, Mitsuoka C, et al: Increased concentration of soluble E-Selectin in the sera of breast cancer patients. Anticancer Res 17: 1367-1372, 1997.
19. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
20. Liotta LA, Kleinerman J and Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34: 997-1004, 1974.
21. Charpin C, Devictor B, Bergeret D, et al: CD31 quantitative immunocytochemical assays in breast carcinomas: correlation with current prognostic factors. Am J Clin Pathol 103: 443-448, 1995.
22. Charpin C, Garcia S, Bouvier C, et al: CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas. Correlation with patient follow-up. Am J Clin Pathol 107: 534-541, 1997.
23. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology 19: 403-410, 1991.
24. Le Doussal V, Tubiana-Hulin M, Friedman S, et al: Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): an improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64: 1914-1921, 1989.
25. Galea MH, Blarney RW, Elston CE, et al: The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 22: 207-219, 1992.
26. Charpin C, Andrac L, Lavaut MN, et al: Image cytometry of aneuploidy, growth fraction (MoAb Ki-67) and hormone receptors (ER, PR) immunocytochemical assays in breast carcinomas. Anal Cell Pathol 2: 357-371, 1990.
27. Charpin C, Andrac L, Vacheret H, et al: Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma tissue sections. Cancer Res 48: 4368-4374, 1988.
28. Charpin C, Vielh P, Duffaud, F, et al: Quantitative immunocyto-chemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohisto-chemical prognostic indicators. J Natl Cancer Inst 86: 1539-1545, 1994.
29. Charpin C, Devictor B, Andrac L, et al: P-53 quantitative immunocytochemical analysis in breast carcinomas. Hum Pathol 26: 159-166, 1995.
30. Charpin C, Garcia S, Bouvier C, et al: Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas. Hum Pathol 28: 289-296, 1997.
31. Charpin C, Garcia S, Bouvier C, et al: E-Cadherin quantitative immunocytochemical assays in breast carcinomas. J Pathol 181: 294-300, 1997.
32. Charpin C, Martin PM, Devictor B, et al: Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assays in 400 human breast carcinomas analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data. Cancer Res 48: 1578-1586, 1988.
33. Grogan TM, Casey TT, Miller P, et al: Automation of immunohistochemistry. Adv Pathol Lab Med 6: 253-283, 1993.
34. Brugal G, Garbay C and Giroud-Adhel D: A double scanning microphotometer for image analysis: hardware, software and biomedical application. J Histochem Cytochem 27: 144, 1979.
35. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
36. Nguyen M, Corless CL, Kräling BM, Tran C, Atha T, Bischoff J and Barsky SH: Vascular expression of E-Selectin is increased in estrogen-receptor-negative breast cancer. A role for tumor-cell-secreted interleukin-1α. Am J Pathol 150: 1307-1314, 1997.
37. Elices MJ, Osborn L, Takada Y, et al: VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577-584, 1990.
38. Albelda SM, Mette SA, Elder DE, et al: Integrin distribution in malignant melanoma: association of the B3 subunit with tumor progression. Cancer Res 50: 6757-6764, 1990.
39. Gehlsen KR, Davis GE and Sriramarao P: Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 10: 111-120, 1992.
40. Wielanga VJ, Heider K, Offerhaus JA, et al: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756, 1993.